About this Journal Submit a Manuscript Table of Contents
Clinical and Developmental Immunology
Volume 2013 (2013), Article ID 453058, 10 pages
http://dx.doi.org/10.1155/2013/453058
Review Article

An Innovative Method to Identify Autoantigens Expressed on the Endothelial Cell Surface: Serological Identification System for Autoantigens Using a Retroviral Vector and Flow Cytometry (SARF)

1Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine, 1-1 Seiryo-cho, Aoba-ku, Sendai, Miyagi 980-8574, Japan
2Department of Histopathology, Tohoku University Graduate School of Medicine, 1-1 Seiryo-cho, Aoba-ku, Sendai, Miyagi 980-8574, Japan

Received 21 September 2012; Revised 20 November 2012; Accepted 21 November 2012

Academic Editor: Xavier Bossuyt

Copyright © 2013 Tsuyoshi Shirai et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. V. Racanelli, M. Prete, G. Musaraj, F. Dammacco, and F. Perosa, “Autoantibodies to intracellular antigens: generation and pathogenetic role,” Autoimmunity Reviews, vol. 10, no. 8, pp. 503–508, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Lleo, P. Invernizzi, B. Gao, M. Podda, and M. E. Gershwin, “Definition of human autoimmunity—autoantibodies versus autoimmune disease,” Autoimmunity Reviews, vol. 9, no. 5, pp. A259–A266, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Davidson and B. Diamond, “Autoimmune diseases,” The New England Journal of Medicine, vol. 345, no. 5, pp. 340–350, 2001. View at Scopus
  4. Y. Naparstek and P. H. Plotz, “The role of autoantibodies in autoimmune disease,” Annual Review of Immunology, vol. 11, pp. 79–104, 1993. View at Scopus
  5. O. Bloom, K. F. Cheng, M. He et al., “Generation of a unique small molecule peptidomimetic that neutralizes lupus autoantibody activity,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 25, pp. 10255–10259, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. K. J. Lindqvist and C. K. Osterland, “Human antibodies to vascular endothelium,” Clinical & Experimental Immunology, vol. 9, no. 6, pp. 753–760, 1971. View at Scopus
  7. P. Guilpain and L. Mouthon, “Antiendothelial cells autoantibodies in vasculitis-associated systemic diseases,” Clinical Reviews in Allergy and Immunology, vol. 35, no. 1-2, pp. 59–65, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. P. Youinou, “New target antigens for antiendothelial cell antibodies,” Immunobiology, vol. 210, no. 10, pp. 789–797, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. T. Shirai, H. Fujii, M. Ono et al., “A novel autoantibody against fibronectin leucine-rich transmembrane protein 2 expressed on the endothelial cell surface identified by retroviral vector system in systemic lupus erythematosus,” Arthritis Research & Therapy, vol. 14, no. 4, article R157, 2012.
  10. E. Romas, B. Paspaliaris, A. J. d'Apice, and P. R. Elliott, “Autoantibodies to neutrophil cytoplasmic (ANCA) and endothelial cell surface antigens (AECA) in chronic inflammatory bowel disease,” Australian and New Zealand Journal of Medicine, vol. 22, no. 6, pp. 652–659, 1992. View at Scopus
  11. A. G. Wangel, S. Kontiainen, L. Melamies, and T. Weber, “Hypothyroidism and anti-endothelial cell antibodies,” Acta Pathologica, Microbiologica, et Immunologica Scandinavica, vol. 101, no. 1, pp. 91–94, 1993. View at Scopus
  12. H. Gur, G. Shen, M. Sutjita et al., “Autoantibody profile of primary sclerosing cholangitis,” Pathobiology, vol. 63, no. 2, pp. 76–82, 1995. View at Scopus
  13. C. Edelsten and D. P. D'Cruz, “Antiendothelial cell antibodies (AECA) in patients with uveoretinitis,” Clinical Reviews in Allergy and Immunology, vol. 15, no. 1, pp. 41–52, 1997. View at Scopus
  14. M. Toyoda, K. Galfayan, O. A. Galera, A. Petrosian, L. S. C. Czer, and S. C. Jordan, “Cytomegalovirus infection induces anti-endothelial cell antibodies in cardiac and renal allograft recipients,” Transplant Immunology, vol. 5, no. 2, pp. 104–111, 1997. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Praprotnik, M. Blank, Y. Levy et al., “Anti-endothelial cell antibodies from patients with thrombotic thrombocytopenic purpura specifically activate small vessel endothelial cells,” International Immunology, vol. 13, no. 2, pp. 203–210, 2001. View at Scopus
  16. D. P. Papadopoulos, T. K. Makris, U. Papazachou, M. Daskalaki, E. Sanidas, and V. E. Votteas, “Antiendothelial cell antibody levels in patients with masked hypertension,” International Journal of Cardiology, vol. 130, no. 3, pp. 405–408, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. T. Matsui, N. Inui, T. Suda, and K. Chida, “Anti-endothelial cell antibodies in patients with interstitial lung diseases,” Respiratory Medicine, vol. 102, no. 1, pp. 128–133, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Karayama, N. Inui, T. Suda, Y. Nakamura, H. Nakamura, and K. Chida, “Antiendothelial cell antibodies in patients with COPD,” Chest, vol. 138, no. 6, pp. 1303–1308, 2010. View at Publisher · View at Google Scholar
  19. E. Elsheikh, C. Sylvén, and L. Henareh, “Anti-endothelial cell antibodies are increased in patients with previous myocardial infarction,” Scandinavian Cardiovascular Journal, vol. 44, no. 5, pp. 255–259, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. C. M. Magro, J. C. Poe, M. Lubow, and J. O. Susac, “Susac syndrome: an organ-specific autoimmune endotheliopathy syndrome associated with anti-endothelial cell antibodies,” American Journal of Clinical Pathology, vol. 136, no. 6, pp. 903–912, 2011.
  21. K. Lewandowska, M. Ciurzynski, E. Gorska et al., “Antiendothelial cells antibodies in patients with systemic sclerosis in relation to pulmonary hypertension and lung fibrosis,” Advances in Experimental Medicine and Biology, vol. 756, pp. 147–153, 2013.
  22. C. Mihai and J. W. C. Tervaert, “Anti-endothelial cell antibodies in systemic sclerosis,” Annals of the Rheumatic Diseases, vol. 69, no. 2, pp. 319–324, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. R. Karasawa, K. Yudoh, S. Ozaki, and T. Kato, “Anti-endothelial cell antibodies (AECA) in patients with systemic vasculitis: our research using proteomics,” Expert Opinion on Biological Therapy, vol. 11, no. 1, pp. 77–87, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. Y. Renaudineau, C. Dugué, M. Dueymes, and P. Youinou, “Antiendothelial cell antibodies in systemic lupus erythematosus,” Autoimmunity Reviews, vol. 1, no. 6, pp. 365–372, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. N. Ronda, S. Leonardi, G. Orlandini et al., “Natural anti-endothelial cell antibodies (AECA),” Journal of Autoimmunity, vol. 13, no. 1, pp. 121–127, 1999. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Servettaz, P. Guilpain, N. Tamas, S. V. Kaveri, L. Camoin, and L. Mouthon, “Natural anti-endothelial cell antibodies,” Autoimmunity Reviews, vol. 7, no. 6, pp. 426–430, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. C. Page, M. Rose, M. Yacoub, and R. Pigott, “Antigenic heterogeneity of vascular endothelium,” American Journal of Pathology, vol. 141, no. 3, pp. 673–683, 1992. View at Scopus
  28. K. Miura, K. Aoun, S. Yoshida, and Y. Kurosawa, “Autoantibodies directed against labile epitopes on cell surface proteins in autoimmune disease patients: proposal of a novel ELISA for the detection of anti-endothelial cell antibodies,” Journal of Immunological Methods, vol. 382, no. 1-2, pp. 32–39, 2012. View at Publisher · View at Google Scholar
  29. M. Damianovich, B. Gilburd, J. George et al., “Pathogenic role of anti-endothelial cell antibodies in vasculitis: an idiotypic experimental model,” Journal of Immunology, vol. 156, no. 12, pp. 4946–4951, 1996. View at Scopus
  30. S. K. Chauhan, N. K. Tripathy, and S. Nityanand, “Antigenic targets and pathogenicity of anti-aortic endothelial cell antibodies in Takayasu arteritis,” Arthritis and Rheumatism, vol. 54, no. 7, pp. 2326–2333, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. N. Del Papa, L. Guidali, M. Sironi et al., “Anti-endothelial cell IgG antibodies from patients with Wegener’s granulomatosis bind to human endothelial cells in vitro and induce adhesion molecule expression and cytokine secretion,” Arthritis and Rheumatism, vol. 39, no. 5, pp. 758–766, 1996. View at Publisher · View at Google Scholar · View at Scopus
  32. S. S. Ahmed, F. K. Tan, F. C. Arnett, L. Jin, and Y. J. Geng, “Induction of apoptosis and fibrillin 1 expression in human dermal endothelial cells by scleroderma sera containing anti-endothelial cell antibodies,” Arthritis and Rheumatism, vol. 54, no. 7, pp. 2250–2262, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. N. K. Tripathy, S. Upadhyaya, N. Sinha, and S. Nityanand, “Complement and cell mediated cytotoxicity by antiendothelial cell antibodies in Takayasu’s arteritis,” Journal of Rheumatology, vol. 28, no. 4, pp. 805–808, 2001. View at Scopus
  34. D. Y. M. Leung, J. L. Moake, P. L. Havens, M. Kim, and J. S. Pober, “Lytic anti-endothelial cell antibodies in haemolytic-uraemic syndrome,” Lancet, vol. 2, no. 8604, pp. 183–186, 1988. View at Scopus
  35. M. Fujieda, N. Oishi, and T. Kurashige, “Antibodies to endothelial cells in Kawasaki disease lyse endothelial cells without cytokine pretreatment,” Clinical & Experimental Immunology, vol. 107, no. 1, pp. 120–126, 1997. View at Scopus
  36. S. H. Tannenbaum, R. Finko, and D. B. Cines, “Antibody and immune complexes induce tissue factor production by human endothelial cells,” Journal of Immunology, vol. 137, no. 5, pp. 1532–1537, 1986. View at Scopus
  37. Y. Renaudineau, E. Grunebaum, I. Krause et al., “Anti-endothelial cell antibodies (AECA) in systemic sclerosis—increased sensitivity using different endothelial cell substrates and association with other autoantibodies,” Autoimmunity, vol. 33, no. 3, pp. 171–179, 2001. View at Scopus
  38. A. Bordron, M. Dueymes, Y. Levy et al., “Anti-endothelial cell antibody binding makes negatively charged phospholipids accessible to antiphospholipid antibodies,” Arthritis & Rheumatism, vol. 41, no. 10, pp. 1738–1747, 1998.
  39. R. Sgonc, M. S. Gruschwitz, G. Boeck, N. Sepp, J. Gruber, and G. Wick, “Endothelial cell apoptosis in systemic sclerosis is induced by antibody-dependent cell-mediated cytotoxicity via CD95,” Arthritis & Rheumatism, vol. 43, no. 11, pp. 2550–2562, 2000.
  40. J. Matsuda, M. Gotoh, K. Gohchi, K. Kawasugi, M. Tsukamoto, and N. Saitoh, “Anti-endothelial cell antibodies to the endothelial hybridoma cell line (EAhy926) in systemic lupus erythematosus patients with antiphospholipid antibodies,” British Journal of Haematology, vol. 97, no. 1, pp. 227–232, 1997. View at Scopus
  41. M. Dieudé, J. L. Senécal, and Y. Raymond, “Induction of endothelial cell apoptosis by heat-shock protein 60-reactive antibodies from anti-endothelial cell autoantibody-positive systemic lupus erythematosus patients,” Arthritis and Rheumatism, vol. 50, no. 10, pp. 3221–3231, 2004. View at Publisher · View at Google Scholar · View at Scopus
  42. P. Margutti, P. Matarrese, F. Conti et al., “Autoanitbodies to the C-terminal subunit of RLIP76 induce oxidative stress and endothelial call apoptosis in immune-mediated vascular diseases and atherosclerosis,” Blood, vol. 111, no. 9, pp. 4559–4570, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. J. E. Alard, S. Hillion, L. Guillevin et al., “Autoantibodies to endothelial cell surface ATP synthase, the endogenous receptor for hsp60, might play a pathogenic role in vasculatides,” PLoS One, vol. 6, no. 2, article e14654, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. Y. Renaudineau, R. Revelen, Y. Levy et al., “Anti-endothelial cell antibodies in systemic sclerosis,” Clinical and Diagnostic Laboratory Immunology, vol. 6, no. 2, pp. 156–160, 1999. View at Scopus
  45. D. W. Koenig, L. Barley-Maloney, and T. O. Daniel, “A western blot assay detects autoantibodies to cryptic endothelial antigens in thrombotic microangiopathies,” Journal of Clinical Immunology, vol. 13, no. 3, pp. 204–211, 1993. View at Publisher · View at Google Scholar · View at Scopus
  46. N. Del Papa, D. Gambini, and P. L. Meroni, “Anti-endothelial cell antibodies and autoimmune diseases,” Clinical Reviews in Allergy, vol. 12, no. 3, pp. 275–286, 1994. View at Publisher · View at Google Scholar · View at Scopus
  47. S. Praprotnik, M. Blank, P. L. Meroni, B. Rozman, A. Eldor, and Y. Shoenfeld, “Classification of anti-endothelial cell antibodies into antibodies against microvascular and macrovascular endothelial cells: the pathogenic and diagnostic implications,” Arthritis & Rheumism, vol. 44, no. 7, pp. 1484–1494, 2001.
  48. C. Jamin, C. Dugué, J. Alard et al., “Induction of endothelial cell apoptosis by the binding of anti-endothelial cell antibodies to Hsp60 in vasculitis-associated systemic autoimmune diseases,” Arthritis and Rheumatism, vol. 52, no. 12, pp. 4028–4038, 2005. View at Publisher · View at Google Scholar · View at Scopus
  49. R. Karasawa, M. S. Kurokawa, K. Yudoh, K. Masuko, S. Ozaki, and T. Kato, “Peroxiredoxin 2 is a novel autoantigen for anti-endothelial cell antibodies in systemic vasculitis,” Clinical & Experimental Immunology, vol. 161, no. 3, pp. 459–470, 2010. View at Publisher · View at Google Scholar · View at Scopus
  50. T. Kikuchi, Y. Yoshida, T. Morioka, F. Gejyo, and T. Oite, “Human voltage-dependent anion selective channel 1 is a target antigen for antiglomerular endothelial cell antibody in mixed connective tissue disease,” Modern Rheumatology, vol. 18, no. 6, pp. 570–577, 2008. View at Publisher · View at Google Scholar · View at Scopus
  51. Y. Renaudineau, C. Dugué, M. Dueymes, and P. Youinou, “Antiendothelial cell antibodies in systemic lupus erythematosus,” Autoimmunity Reviews, vol. 1, no. 6, pp. 365–372, 2002. View at Publisher · View at Google Scholar · View at Scopus
  52. K. H. Lee, H. S. Chung, H. S. Kim et al., “Human alpha-enolase from endothelial cells as a target antigen of anti-endothelial cell antibody in Behcet’s disease,” Arthritis and Rheumatism, vol. 48, no. 7, pp. 2025–2035, 2003. View at Publisher · View at Google Scholar · View at Scopus
  53. P. García de la Peña-Lefebvre, Y. Chanseaud, M. C. Tamby et al., “IgG reactivity with a 100-kDa tissue and endothelial cell antigen identified as topoisomerase 1 distinguishes between limited and diffuse systemic sclerosis patients,” Clinical Immunology, vol. 111, no. 3, pp. 241–251, 2004. View at Publisher · View at Google Scholar · View at Scopus
  54. A. Servettaz, M. C. Tamby, P. Guilpain et al., “Anti-endothelial cell antibodies from patients with limited cutaneous systemic sclerosis bind to centromeric protein B (CENP-B),” Clinical Immunology, vol. 120, no. 2, pp. 212–219, 2006. View at Publisher · View at Google Scholar · View at Scopus
  55. M. Dieudé, J. L. Senécal, and Y. Raymond, “Induction of endothelial cell apoptosis by heat-shock protein 60-reactive antibodies from anti-endothelial cell autoantibody-positive systemic lupus erythematosus patients,” Arthritis and Rheumatism, vol. 50, no. 10, pp. 3221–3231, 2004. View at Publisher · View at Google Scholar · View at Scopus
  56. M. Kaneko, T. Ono, T. Matsubara et al., “Serological identification of endothelial antigens predominantly recognized in Kawasaki disease patients by recombinant expression cloning,” Microbiology and Immunology, vol. 48, no. 9, pp. 703–711, 2004. View at Scopus
  57. H. Direskeneli, D. D’Cruz, M. A. Khamashta, and G. R. V. Hughes, “Autoantibodies against endothelial cells, extracellular matrix, and human collagen type IV in patients with systemic vasculitis,” Clinical Immunology and Immunopathology, vol. 70, no. 3, pp. 206–210, 1994. View at Publisher · View at Google Scholar · View at Scopus
  58. P. Heeringa and J. W. Tervaert, “Pathophysiology of ANCA-associated vasculitides: are ANCA really pathogenic?” Kidney International, vol. 65, no. 5, pp. 1564–1567, 2004. View at Publisher · View at Google Scholar · View at Scopus
  59. T. Kitamura, Y. Koshino, F. Shibata et al., “Retrovirus-mediated gene transfer and expression cloning: powerful tools in functional genomics,” Experimental Hematology, vol. 31, no. 11, pp. 1007–1014, 2003. View at Publisher · View at Google Scholar · View at Scopus
  60. S. Morita, T. Kojima, and T. Kitamura, “Plat-E: an efficient and stable system for transient packaging of retroviruses,” Gene Therapy, vol. 7, no. 12, pp. 1063–1066, 2000.
  61. S. E. Lacy, C. G. Bönnemann, E. A. Buzney, and L. M. Kunkel, “Identification of FLRT1, FLRT2, and FLRT3: a novel family of transmembrane leucine-rich repeat proteins,” Genomics, vol. 62, no. 3, pp. 417–426, 1999. View at Publisher · View at Google Scholar · View at Scopus
  62. C. Lawson and S. Wolf, “ICAM-1 signaling in endothelial cells,” Pharmacological Reports, vol. 61, no. 1, pp. 22–32, 2009. View at Scopus
  63. O. Durieu-Trautmann, N. Chaverot, S. Cazaubon, A. D. Strosberg, and P. O. Couraud, “Intercellular adhesion molecule 1 activation induces tyrosine phosphorylation of the cytoskeleton-associated protein cortactin in brain microvessel endothelial cells,” Journal of Biological Chemistry, vol. 269, no. 17, pp. 12536–12540, 1994. View at Scopus
  64. R. Rothlein, T. K. Kishimoto, and E. Mainolfi, “Cross-linking of ICAM-1 induces co-signaling of an oxidative burst from mononuclear leukocytes,” Journal of Immunology, vol. 152, no. 5, pp. 2488–2495, 1994. View at Scopus
  65. S. Etienne-Manneville, J. B. Manneville, P. Adamson, B. Wilbourn, J. Greenwood, and P. O. Couraud, “ICAM-1-coupled cytoskeletal rearrangements and transendothelial lymphocyte migration involve intracellular calcium signaling in brain endothelial cell lines,” Journal of Immunology, vol. 165, no. 6, pp. 3375–3383, 2000. View at Scopus
  66. C. Lawson, M. Ainsworth, M. Yacoub, and M. Rose, “Ligation of ICAM-1 on endothelial cells leads to expression of VCAM-1 via a nuclear factor-kappaB-independent mechanism,” Journal of Immunology, vol. 162, no. 5, pp. 2990–2996, 1999. View at Scopus
  67. H. Sano, N. Nakagawa, R. Chiba, K. Kurasawa, Y. Saito, and I. Iwamoto, “Cross-linking of intercellular adhesion molecule-1 induces interleukin-8 and RANTES production through the activation of MAP kinases in human vascular endothelial cells,” Biochemical and Biophysical Research Communications, vol. 250, no. 3, pp. 694–698, 1998. View at Publisher · View at Google Scholar · View at Scopus
  68. C. Lawson, M. E. Ainsworth, A. M. McCormack, M. Yacoub, and M. L. Rose, “Effects of cross-linking ICAM-1 on the surface of human vascular smooth muscle cells: induction of VCAM-1 but no proliferation,” Cardiovascular Research, vol. 50, no. 3, pp. 547–555, 2001. View at Publisher · View at Google Scholar · View at Scopus
  69. E. Schmid, T. H. Muller, R. M. Budzinski, K. Binder, and K. Pfizenmaier, “Signaling by E-selectin and ICAM-1 induces endothelial tissue factor production via autocrine secretion of platelet-activating factor and tumor necrosis factor alpha,” Journal of Interferon and Cytokine Research, vol. 15, no. 9, pp. 819–825, 1995. View at Scopus
  70. Y. Koyama, Y. Tanaka, K. Saito et al., “Cross-linking of intercellular adhesion molecule 1 (CD54) induces AP-1 activation and IL-1beta transcription,” Journal of Immunology, vol. 157, no. 11, pp. 5097–5103, 1996. View at Scopus
  71. C. Lawson, A. L. Holder, R. E. Stanford, J. Smith, and M. L. Rose, “Anti-intercellular adhesion molecule-1 antibodies in sera of heart transplant recipients: a role in endothelial cell activation,” Transplantation, vol. 80, no. 2, pp. 264–271, 2005. View at Publisher · View at Google Scholar · View at Scopus
  72. A. F. Kavanaugh, H. Schulze-Koops, L. S. Davis, and P. E. Lipsky, “Repeat treatment of rheumatoid arthritis patients with a murine anti- intercellular adhesion molecule 1 monoclonal antibody,” Arthritis and Rheumatism, vol. 40, no. 5, pp. 849–853, 1997. View at Scopus
  73. B. Thuresson, J. S. Westman, and M. L. Olsson, “Identification of a novel A4GALT exon reveals the genetic basis of the P1/P2 histo-blood groups,” Blood, vol. 117, no. 2, pp. 678–687, 2011. View at Publisher · View at Google Scholar · View at Scopus
  74. R. Steffensen, K. Carlier, J. Wiels et al., “Cloning and expression of the histo-blood group PkUDP-galactose: Galβ1–4Glcβ1-Cer α1,4-galactosyltransferase. Molecular genetic basis of the p phenotype,” Journal of Biological Chemistry, vol. 275, no. 22, pp. 16723–16729, 2000. View at Publisher · View at Google Scholar · View at Scopus
  75. M. Mangeney, C. A. Lingwood, S. Taga, B. Caillou, T. Tursz, and J. Wiels, “Apoptosis induced in Burkitt's lymphoma cells via Gb3/CD77, a glycolipid antigen,” Cancer Research, vol. 53, no. 21, pp. 5314–5319, 1993. View at Scopus
  76. L. L. W. Cooling, K. E. Walker, T. Gille, and T. A. W. Koerner, “Shiga toxin binds human platelets via globotriaosylceramide (P(K) antigen) and a novel platelet glycosphingolipid,” Infection and Immunity, vol. 66, no. 9, pp. 4355–4366, 1998. View at Scopus
  77. C. A. Lingwood, “Verotoxin-binding in human renal sections,” Nephron, vol. 66, no. 1, pp. 21–28, 1994. View at Scopus
  78. K. Lindstrom, A. E. G. K. Von dem Borne, M. E. Breimer et al., “Glycosphingolipid expression in spontaneously aborted fetuses and placenta from blood group p women. Evidence for placenta being the primary target for anti-Tja-antibodies,” Glycoconjugate Journal, vol. 9, no. 6, pp. 325–329, 1992. View at Scopus